Gyeonggi-do, South Korea

Pyung Cheon Lee


 

Average Co-Inventor Count = 19.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Pyung Cheon Lee in Diabetes and Obesity Treatment

Introduction

Pyung Cheon Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals and functional foods, particularly in the prevention and treatment of diabetes and obesity. With a total of three patents to his name, Lee's work focuses on innovative compositions that target critical health issues.

Latest Patents

Lee's latest patents revolve around pharmaceutical and food compositions designed to prevent or treat diabetes and obesity. These inventions highlight a novel compound synthesized from an extract, which exhibits excellent inhibitory activities against PTP-1b (protein tyrosine phosphatase-1b). The compounds developed by Lee selectively act on PTP-1b, making them substantial inhibitors that are effective in addressing these health concerns.

Career Highlights

Throughout his career, Pyung Cheon Lee has been associated with prominent research institutions, including the Korea Ocean Research and Development Institute and the Korea Ocean Research Institute. His work in these organizations has allowed him to advance his research and contribute to significant innovations in health-related fields.

Collaborations

Lee has collaborated with notable colleagues such as Joung Han Yim and Il Chan Kim. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Pyung Cheon Lee's innovative work in developing pharmaceutical and food compositions for diabetes and obesity prevention showcases his commitment to addressing critical health issues. His contributions are significant in the realm of health sciences, and his patents reflect a dedication to improving public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…